Cost Plus Enters Biologics Arena With Low-Cost Humira Biosimilar

By Beth Wang / June 1, 2023 at 2:06 PM
Coherus BioSciences in July will launch its Humira biosimilar, Yusimry, which will be available through Mark Cuban’s online generic pharmacy Cost Plus Drug Company at a price of $579 plus shipping, marking the first biologic offered by Cost Plus, the companies announced Thursday (June 1) . Two weeks before the announcement, Cuban also indicated Cost Plus , which offers generics at a lower price, will begin manufacturing injectable drugs that are in shortage. Humira, an injectable that’s approved to treat...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.